The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication

Journal of Virology

Volumn 70, Issue 2, 1996, Pages 689-696

  De Vreese, Karen ^a   Kofler Mongold, Vera ^b   Leutgeb, Claudia ^b   Weber, Virginia ^b   Vermeire, Kurt ^a   Schacht, Sabine ^a   Anné, Jozef ^a   De Clercq, Erik ^a   Datema, Roelf ^b   Werner, Gudrun ^b  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

1,1' PROPYLENEBIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); 1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); ANTIVIRUS AGENT; BICYCLAM DERIVATIVE; CD4 ANTIGEN; CYCLAM DERIVATIVE; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; JM 2763; UNCLASSIFIED DRUG; VIRUS REPLICATION INHIBITORY PEPTIDE;

AMINO ACID SUBSTITUTION; ANTIVIRAL ACTIVITY; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; ENVELOPE GENE; GENETIC ANALYSIS; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; LIFE CYCLE; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL; PROTEIN FOLDING; VIRUS ADSORPTION; VIRUS MUTATION; VIRUS REPLICATION;

EID: 0003973947     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.2.689-696.1996     Document Type: Article

References (40)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291
2. Baba, M., R. Paawels, J. Balzarini, J. Arnout, J. Desmyter, and E. De Clercq. 1988. Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proc. Natl. Acad. Sci. USA 85:6132-6136.
3. Balzarini, J., A. Karlsson, M.-J. Perez Perez, L. Vrang, J. Walbers, H. Zhang, B. Oberg, A.-M. Vandamme, M. J. Camarasa, and E. De Clercq. 1993. HIV-1-specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptase. Virology 192:246-253.
4. Batinic, D., and F. A. Robey. 1992. The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides. J. Biol. Chem. 267:6664-6671.
5. Bloom, D. C., and J. G. Stevens. 1994. Neuron-specific restriction of a herpes simplex virus recombinant maps to the UL5 gene. J. Virol. 68:3761-3772.
6. Bridger, G. J., R. T. Skerlj, D. Thornton, S. Padmanabhan, S. A. Martellucci, G. W. Henson, M. J. Abrams, N. Yamamoto, K. De Vreese, R. Pauwels, and E. De Clercq. 1995. Synthesis and structure-activity relationships of phenylenebis-(methylene)-linked bis-tetraazamacrocycles that inhibit HIV replication Effects of macrocyclic ring size and substituents on the aromatic linker. J. Med. Chem. 38:366-378.
7. Callahan, L. N., M. Phelan, M. Mallinson, and M. A. Norcross. 1991. Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions J Virol. 65:1543-1550.
8. Callebaut, C., B. Krust, E. Jacotot, and A. G. Hovanessian. 1993. T cell activation antigen. CD26, as a cofactor for entry of HIV in CD4+ cells. Science 262:2045-2050.
9. Capon, D. J., and R. H. Ward. 1991. The CD4-gp120 interaction and AIDS pathogenesis Annu. Rev. Immunol. 9:649-678.
10. Catasti, P., J. D. Fontenot, E. M. Bradbury, and G. Gupta. 1995. Local and global structural properties, of the HIV-MN V3 loop. J. Biol. Chem. 270:2224-2232.
11. Chiou, S. H., E. O. Freed, A. T. Panganiban, and W. R. Kenealy. 1992. Studies on the role of the V3 loop in human immunodeficiency virus type 1 envelope glycoprotein function. AIDS Res Hum Retroviruses 8:1611-1618.
12. Clements, G. J., M. J. Price-Jones, P. E. Stephens, C. Sutton, T. F. Schulz, P. R. Clapham, J. A. McKeating, M. O. McClure, S. Thomson, and M. Marsh. 1991. The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion? AIDS Res. Hum. Retroviruses 7:3-16.
13. Coffin, J. M. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267:483-489.
14. De Clercq, E., N. Yamamoto, R. Pauwels, M. Baba, D. Schols, H. Nakashima, J. Balzarini, Z. Debyser, B. A. Murrer, D. Schwartz, D. Thornton, G. J. Bridger, S. Fricker, G. W. Hensoo, M. J. Abrams, and D. Picker. 1992. Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event. Proc Natl. Acad. Sci. USA 89:5286-5290.
15. De Clercq, E., N. Yamamoto, R. Pauwels, J. Balzarini, M. Witvrouw, K. De Vreese, Z. Debyser, B. Rosenwirth, P. Peichl, R. Datema, D. Thornton, R. T. Skerlj, F. Gaul, S. Padmanadhan, G. J. Bridger, G. W. Henson, and M. J. Abrams. 1994. Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100. Antimicrob. Agents Chemother. 38:668-674.
16. De Vreese, K., D. Reymen, P. Griffin, A. Steinkasserer, G. Werner, G. J. Bridger, J. Esté, W. James, G. W. Henson, J. Desmyter, J. Anné, and E. De Clercq. The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after binding. Antiviral Res., in press.
17. Esté, J., K. De Vreese, M. Witvrouw, J.-C. Schmit, A.-M. Vandamme, J. Anné, J. Desmyter, G. W. Henson, G. Bridger, and E. De Clerq. Antiviral activity of the bicyclam derivative SID791 (JM3100) against drug-resistant strains of human immunodeficiency virus type 1. Submitted for publication.
18. Gorelick, R. J., D. J. Chabot, A. Rein, L. E. Henderson, and L. O. Arthur. 1993 The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent. J. Virol. 67:4027-4036.
19. Gu, R., P. Westervelt, and L. Ratner. 1993. Role of HIV-1 envelope V3 loop cleavage in cell tropism. AIDS Res. Hum. Retroviruses 9:1007-1015.
20. Hammer, S. M., H. A. Kessler, and M. S. Saag. 1994. Issues in combination antiretroviral therapy, a review. J Acquired Immune Defic Syndr. 7(Suppl 2):S24-S35.
21. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 373:123-126.
22. Ho, D. D., T. Toyoshima, H. Mo, D. J. Kempf, D. Norbeck, C. M. Chen, N. E. Wideburg, S. K. Burt, J. W. Erickson, and M. K. Singh. 1994. Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric protease inhibitor. J Virol 68:2016-2020.
23. Jacobsen, H., K. Yasargil, D. L. Winslow, J. C. Craig, A. Krohn, I. B. Duncan, and J. Mous. 1995. Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959 Virology 206:527-534.
24. Korber, B. T. M., K. MacInnes, R. F. Smith, and G. Myers. 1994. Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1 J. Virol. 68:6730-6744.
25. Larder, B. A. 1992. 3′-Azido-3′-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors. Antimicrob. Agents Chemother 36:2664-2669.
26. Matthews, T. J., C. Wild, C. H. Chen, D. P. Bolognesi, and M. L. Greenberg. 1994. Structural rearrangements in the transmembrane glycoprotein after receptor binding. Immunol. Rev. 140:93-104.
27. McClure, M. O., J. P. Moore, D. F. Blanc, P. Scotting, G. M. Cook, R. J. Keynes, J. N. Weber, D. Davies, and R. A. Weiss. 1992. Investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro. AIDS Res. Hum. Retroviruses 8:19-26.
28. McLachlin, J. R., and L. K. Miller. 1994. Identification and characterization of vlf-1, a baculovirus gene involved in very late gene expression. J. Virol 68:7746-7756.
29. Mellors, J. W., G. E. Dutschman, G. J. Im, E. Tramontano, S. R. Winkler, and Y. C. Cheng. 1992. In vitro selection and molecular characterization of human immunodeficiency virus-1 resistant to non-nucleoside inhibitors of reverse transcriptase Mol. Pharmacol. 41:445-451. (Erratum. 42:174.)
30. Meshcheryakova, D., S. Andreev, S. Tarasova, M. Sidorova, M. Vafina, G. Kornilaeva, E. Karamov, and R. Khaitov. 1993. CD4-derived peptide and sulfated polysaccharides have similar mechanisms of anti-HIV activity based on electrostatic interactions with positively charged gp120 fragments. Mol Immunol. 30:993-1001.
31. Pauwels, R., J. Balzarini, M. Baba, R. Snoeck, D. Schols, P. Herdewijn, J. Desmyter, and E. De Clercq. 1988. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods 20:309-321.
32. Rice, W. G., C. A. Schaeffer, B. Harten, F. Villinger, T. L. South, M. F. Summers, L. E. Henderson, J. W. Bess, Jr., L. O. Arthur, J. S. McDougal, S. L. Orloff, J. Mendeleyev, and E. Kun. 1993 Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds. Nature (London) 361:473-475.
33. Ryser, H. J., E. M. Levy, R., Mandel, and G. J. DiSciullo. 1994. Inhibition of human immunodeficiency virus infection by agents that interfere with thioldisulfide interchange upon virus-receptor interaction. Proc. Natl. Acad Sci USA 91:4559-4563
34. Sattentau, Q. J. 1992. CD4 activation of HIV fusion. Int. J. Cell Cloning 10:323-332.
35. South, T. L., and M. F. Summers. 1993. Zinc- and sequence-dependent binding to nucleic acids by the N-terminal zinc finger of the HIV-1 nucleocapsid protein: NMR structure of the complex with the Psi-site analog, dACGCC. Protein Sci. 2:3-19.
36. Stein, B. S., and E. G. Engleman. 1991. Mechanism of HIV-1 entry into CD4+ T cells Adv Exp. Med Biol. 300:71-86.
37. Tang, Q., and H. S. Ginsberg. 1994. trans-dominant interference of type 5 adenovirus E1a mutants in cell transformation. J. Virol. 68:2127-2134.
38. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 373:117-122
39. Werner, A., and J. A. Levy. 1993. Human immunodeficiency virus type 1 envelope gp120 is cleaved after incubation with recombinant soluble CD4. J. Virol 67:2566-2574.
40. Wu, X., W. Xiao, and J. L. Brandsma. 1994. Papilloma formation by cotton-tail rabbit papillomavirus requires E1 and E2 regulatory genes in addition to E6 and E7 transforming genes. J. Virol. 68:6097-6102.